The abstract is read at the publisher; the summary is JClub's.
cGAS is the primary sensor of LNP-encapsulated DNA in mice, and its downstream interferon and inflammatory pathways drive systemic toxicity and reduce transgene expression.
- Why it matters: DNA gene therapy is limited by unintended innate immune activation that undermines safety and sustained efficacy, especially after systemic dosing.
- What they did: In mouse models, investigators mapped toxicity mechanisms after intravenous LNP-DNA delivery, identifying cGAS-driven type I interferon signaling and inflammatory responses, with TREX1 degrading DNA and TNF-α mediating liver injury.
- The result: Prophylactic immune modulation with dexamethasone or a JAK inhibitor alleviated LNP-DNA toxicity, and dexamethasone showed a significantly stronger inhibitory effect on adverse effects.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.